GRANULES: Q1 FY27 consolidated net profit rose to Rs 1,799.63 million, with ongoing USFDA compliance actions
Standalone and consolidated Q1 FY27 results show year-over-year growth in revenue and net profit, with consolidated net profit rising to Rs 1,799.63 million. Regulatory risks persist due to a USFDA warning, but corrective actions are underway.Original document: Granules India Limited [GRANULES] Int…